IZI Medical Products

IZI Medical Products was founded in 1991 by a neuroradiologist and radiation oncologist who wanted to improve procedural accuracy and reduce time. The company remains focused on physician-inspired innovation in interventional radiology and spine care (per the firm's website, 2025).

IZI Medical Products is an operating medical device company, not a family office. It manufactures and distributes consumable devices used in interventional radiology, oncology, and spine procedures. The company is owned by Halma plc, a publicly traded UK-based industrial group (per Halma plc, 2025).

IZI Medical Products does not invest capital externally; it is a portfolio company of Halma plc. Halma operates as a buy-and-hold acquirer of life-saving technology businesses, typically acquiring established companies with strong intellectual property and growth potential. IZI was likely an add-on acquisition within Halma's healthcare sector.

IZI operates as a standalone subsidiary of Halma plc, which provides long-term capital and strategic support without requiring a near-term exit. This ownership allows IZI to focus on product development and physician partnerships rather than quarterly earnings pressure. Halma's model emphasizes autonomous operations and decentralized decision-making (per Halma plc, 2025).

IZI sells to more than 2,000 domestic customers in the United States and distributes products in 25 countries internationally. The company's headquarters is in Owings Mills, Maryland, and it does not disclose any additional office locations (per the firm's website, 2025).

IZI's portfolio includes soft tissue biopsy systems (Quick-Core Auto Biopsy Needle), breast localization products, vertebral augmentation systems (Blazer-C, Osteo-Site balloon), and bone cement for vertebroplasty and kyphoplasty (Vertefix MV). The company also has products for image-guided surgery and radiation therapy (per the firm's website, 2025).

IZI Medical Products does not publicly disclose its AUM, revenue, profitability, or number of employees. Financial data for the company is reported within Halma plc's consolidated filings, which are publicly available but not broken out for individual subsidiaries (Altss research).